Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: Keyword is Muscle, Skeletal  [Clear All Filters]
2024
Hussain I, Kim SEun, Kwon C, Hoon SKyung, Kim HChan, Ku Y, Ro DHyun.  2024.  Estimation of patient-reported outcome measures based on features of knee joint muscle co-activation in advanced knee osteoarthritis.. Sci Rep. 14(1):12428.
2008
Accardi A.  2008.  To ATP or not to ATP: this is the question.. J Gen Physiol. 131(2):105-8.
2007
Ouyang W, Hemmings HC.  2007.  Isoform-selective effects of isoflurane on voltage-gated Na+ channels.. Anesthesiology. 107(1):91-8.
Liantonio A, Giannuzzi V, Picollo A, Babini E, Pusch M, D Camerino C.  2007.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.. Br J Pharmacol. 150(2):235-47.
2003
Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA et al..  2003.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.. J Med Chem. 46(12):2502-15.
Schlame M, Kelley RI, Feigenbaum A, Towbin JA, Heerdt PM, Schieble T, Wanders RJA, DiMauro S, Blanck TJJ.  2003.  Phospholipid abnormalities in children with Barth syndrome.. J Am Coll Cardiol. 42(11):1994-9.
Liantonio A, De Luca A, Pierno S, Didonna MPaola, Loiodice F, Fracchiolla G, Tortorella P, Antonio L, Bonerba E, Traverso S et al..  2003.  Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.. Br J Pharmacol. 139(7):1255-64.
Moran O, Picollo A, Conti F.  2003.  Tonic and phasic guanidinium toxin-block of skeletal muscle Na channels expressed in Mammalian cells.. Biophys J. 84(5):2999-3006.
2002
Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ.  2002.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.. Ann Neurol. 51(5):634-7.
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
1999
Nimigean CM, Magleby KL.  1999.  The beta subunit increases the Ca2+ sensitivity of large conductance Ca2+-activated potassium channels by retaining the gating in the bursting states.. J Gen Physiol. 113(3):425-40.
1995
Riker WF, Okamoto M, Artusio JF.  1995.  In vivo reversal of depolarizing neuromuscular blockade.. Arch Int Pharmacodyn Ther. 330(1):90-101.
1958
TRIGO ER, PICOLLO AM, PAZ MR, MOSTO A.  1958.  [Preescalénica biopsy].. Prensa Med Argent. 45(36):3005-8.